KLHL11
gene geneOn this page
Also known as FLJ10572
Summary
KLHL11 (kelch like family member 11, HGNC:19008) is a protein-coding gene on chromosome 17q21.2, encoding Kelch-like protein 11 (Q9NVR0). Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation. It is a selective cancer dependency (DepMap: 10.4% of cell lines).
Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be part of Cul3-RING ubiquitin ligase complex. Predicted to be active in cytoplasm.
Source: NCBI Gene 55175 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 50 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 10.4% of screened cell lines
- MANE Select transcript:
NM_018143
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19008 |
| Approved symbol | KLHL11 |
| Name | kelch like family member 11 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10572 |
| Ensembl gene | ENSG00000178502 |
| Ensembl biotype | protein_coding |
| OMIM | 619078 |
| Entrez | 55175 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000319121
RefSeq mRNA: 1 — MANE Select: NM_018143
NM_018143
CCDS: CCDS11411
Canonical transcript exons
ENST00000319121 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001291142 | 41864826 | 41865423 |
| ENSE00002549532 | 41848518 | 41855321 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 89.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.0005 / max 138.0397, expressed in 1775 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166054 | 6.7119 | 1648 |
| 166053 | 5.0428 | 1639 |
| 166055 | 1.2458 | 733 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 89.44 | gold quality |
| male germ cell | CL:0000015 | 86.99 | gold quality |
| secondary oocyte | CL:0000655 | 82.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.72 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.27 | gold quality |
| tendon | UBERON:0000043 | 77.75 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.62 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.60 | gold quality |
| cortical plate | UBERON:0005343 | 75.72 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.07 | gold quality |
| medial globus pallidus | UBERON:0002477 | 74.53 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 73.46 | gold quality |
| ventricular zone | UBERON:0003053 | 72.89 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.80 | gold quality |
| monocyte | CL:0000576 | 71.55 | gold quality |
| mononuclear cell | CL:0000842 | 71.46 | gold quality |
| leukocyte | CL:0000738 | 71.24 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.57 | gold quality |
| gastrocnemius | UBERON:0001388 | 68.87 | gold quality |
| muscle of leg | UBERON:0001383 | 68.42 | gold quality |
| testis | UBERON:0000473 | 67.71 | gold quality |
| globus pallidus | UBERON:0001875 | 67.40 | gold quality |
| left testis | UBERON:0004533 | 67.02 | gold quality |
| right testis | UBERON:0004534 | 66.98 | gold quality |
| colonic epithelium | UBERON:0000397 | 66.17 | silver quality |
| pancreas | UBERON:0001264 | 65.03 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 64.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 63.99 | gold quality |
| corpus callosum | UBERON:0002336 | 63.85 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 63.83 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6058 | no | 717.22 |
| E-ANND-3 | no | 4.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
258 targeting KLHL11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 10.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- analysis of crystal structures of the BTB-BACK domains of KLHL11 both alone and in complex with Cul3 (PMID:23349464)
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. (PMID:32744608)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | klhl11 | ENSDARG00000045130 |
| mus_musculus | Klhl11 | ENSMUSG00000048732 |
| rattus_norvegicus | Klhl11 | ENSRNOG00000016921 |
| drosophila_melanogaster | BTBD9 | FBGN0030228 |
| drosophila_melanogaster | CG17068 | FBGN0031098 |
| drosophila_melanogaster | lute | FBGN0262871 |
| caenorhabditis_elegans | WBGENE00015463 |
Paralogs (11): BTBD1 (ENSG00000064726), ABTB1 (ENSG00000114626), SPOP (ENSG00000121067), KBTBD4 (ENSG00000123444), BTBD3 (ENSG00000132640), BTBD2 (ENSG00000133243), SPOPL (ENSG00000144228), ABTB3 (ENSG00000151136), ABTB2 (ENSG00000166016), BTBD9 (ENSG00000183826), BTBD6 (ENSG00000184887)
Protein
Protein identifiers
Kelch-like protein 11 — Q9NVR0 (reviewed: Q9NVR0)
All UniProt accessions (1): Q9NVR0
UniProt curated annotations — full annotation on UniProt →
Function. Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation.
Subunit / interactions. Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. Homodimer. Interacts with CUL3.
RefSeq proteins (1): NP_060613* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
Pfam: PF00651, PF07707, PF13964
UniProt features (41 total): helix 19, strand 6, turn 5, repeat 5, domain 2, signal peptide 1, chain 1, modified residue 1, region of interest 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3I3N | X-RAY DIFFRACTION | 2.6 |
| 4AP2 | X-RAY DIFFRACTION | 2.8 |
| 4APF | X-RAY DIFFRACTION | 3.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NVR0-F1 | 82.68 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 465
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
MSigDB gene sets: 135 (showing top):
GCM_GSPT1, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, OCT1_06, GCM_NF2, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX, WGTTNNNNNAAA_UNKNOWN, E2F1_Q3_01
GO Biological Process (1): proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)
GO Molecular Function (2): ubiquitin-like ligase-substrate adaptor activity (GO:1990756), protein binding (GO:0005515)
GO Cellular Component (3): cytoplasm (GO:0005737), cytosol (GO:0005829), Cul3-RING ubiquitin ligase complex (GO:0031463)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
| Adaptive Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| ubiquitin-dependent protein catabolic process | 1 |
| proteasomal protein catabolic process | 1 |
| enzyme-substrate adaptor activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
550 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL11 | CUL3 | Q13618 | 794 |
| KLHL11 | IGLON5 | A6NGN9 | 587 |
| KLHL11 | LUZP4 | Q9P127 | 581 |
| KLHL11 | SEPTIN5 | Q99719 | 577 |
| KLHL11 | DPYSL5 | Q9BPU6 | 571 |
| KLHL11 | PNMA2 | Q9UL42 | 506 |
| KLHL11 | PDE10A | Q9Y233 | 492 |
| KLHL11 | FBXL15 | Q9H469 | 446 |
| KLHL11 | AMPH | P49418 | 423 |
| KLHL11 | LGI1 | O95970 | 417 |
| KLHL11 | NCDN | Q9UBB6 | 416 |
| KLHL11 | BIN1 | O00499 | 411 |
| KLHL11 | KLHDC2 | Q9Y2U9 | 409 |
| KLHL11 | RBX1 | P62877 | 407 |
| KLHL11 | EOLA2 | Q96DE9 | 400 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RHPN1 | PODXL | psi-mi:“MI:0914”(association) | 0.690 |
| CUL3 | ENC1 | psi-mi:“MI:0914”(association) | 0.640 |
| KLHL11 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IHO1 | KLHL11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU6F2 | KLHL11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CUL3 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.530 |
| PICK1 | ILVBL | psi-mi:“MI:0914”(association) | 0.530 |
| CASQ2 | PES1 | psi-mi:“MI:0914”(association) | 0.530 |
| KIAA0930 | ATG7 | psi-mi:“MI:0914”(association) | 0.530 |
| KLHL11 | NUDCD3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM35 | LIMK2 | psi-mi:“MI:0914”(association) | 0.350 |
| CUL3 | KLHL2 | psi-mi:“MI:0914”(association) | 0.350 |
| CASQ2 | TSNARE1 | psi-mi:“MI:0914”(association) | 0.350 |
| RHPN1 | PODXL | psi-mi:“MI:0914”(association) | 0.350 |
| KIAA0930 | FRYL | psi-mi:“MI:0914”(association) | 0.350 |
| C1QL4 | SMC2 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL11 | PIPSL | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJA2 | DENND11 | psi-mi:“MI:0914”(association) | 0.350 |
| LLCFC1 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| C1QL4 | SRC | psi-mi:“MI:0914”(association) | 0.350 |
| RBAK | CYP24A1 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL11 | PSMD12 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL11 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KLHL11 | IHO1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KLHL11 | POU6F2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (97): KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-MS), KLHL11 (Affinity Capture-Western), KLHL11 (Affinity Capture-Western), KLHL11 (Co-localization), KLHL11 (PCA)
ESM2 similar proteins: A0A1B8YAB1, B1H285, B3DIV9, E9QIN8, E9QJ30, F1QEG2, O88879, Q08CL3, Q08CY1, Q0D2A9, Q13939, Q28068, Q3UQV5, Q3ZCT8, Q503R4, Q5F3N5, Q5R4S6, Q5R663, Q5RG82, Q5XHZ6, Q5XI58, Q5ZI33, Q69ZK5, Q6DFF7, Q6DFU2, Q6Q7X9, Q6V595, Q7ZVQ8, Q86V97, Q8BHI4, Q8BUL5, Q8BWA5, Q8CA72, Q8CDE2, Q8CE33, Q8IXQ5, Q8NAB2, Q8NFY9, Q8R179, Q8WVZ9
Diamond homologs: A0JMG1, A1YEX3, B0WWP2, B3DIV9, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, B7U179, D3Z8N4, D4A2K4, E0CZ16, E7F6F9, F1LZF0, F1MBP6, O14682, O22286, O35709, O43791, O81432, O95198, P0DMR5, P0DMR6, P24278, P28575, P34568, P58544, P58545, Q08DK3, Q08DS0, Q0D2A9, Q0IHH9, Q0VCW1, Q16RL8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
144 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41855322:C:CA | acceptor_loss | 1.0000 |
| 17:41855322:C:CC | acceptor_gain | 1.0000 |
| 17:41855317:GGAAC:G | acceptor_gain | 0.9900 |
| 17:41855318:GAAC:G | acceptor_gain | 0.9900 |
| 17:41855320:AC:A | acceptor_gain | 0.9900 |
| 17:41855321:CC:C | acceptor_gain | 0.9900 |
| 17:41855323:T:A | acceptor_loss | 0.9900 |
| 17:41855329:C:CT | acceptor_gain | 0.9900 |
| 17:41855330:A:T | acceptor_gain | 0.9900 |
| 17:41860893:A:AC | donor_gain | 0.9900 |
| 17:41860894:T:C | donor_gain | 0.9900 |
| 17:41864822:CTACC:C | donor_loss | 0.9900 |
| 17:41864823:TA:T | donor_loss | 0.9900 |
| 17:41864825:C:CT | donor_loss | 0.9900 |
| 17:41855319:AAC:A | acceptor_gain | 0.9800 |
| 17:41859085:C:CA | donor_gain | 0.9800 |
| 17:41864824:A:AC | donor_gain | 0.9800 |
| 17:41864825:C:CC | donor_gain | 0.9800 |
| 17:41855320:ACCT:A | acceptor_gain | 0.9700 |
| 17:41864825:CCTGT:C | donor_gain | 0.9700 |
| 17:41855319:AACCT:A | acceptor_gain | 0.9600 |
| 17:41855321:CCT:C | acceptor_gain | 0.9600 |
| 17:41855322:C:A | acceptor_gain | 0.9600 |
| 17:41855322:C:T | acceptor_gain | 0.9500 |
| 17:41855323:T:G | acceptor_gain | 0.9500 |
| 17:41855318:GAACC:G | acceptor_gain | 0.9200 |
| 17:41862906:A:AC | donor_gain | 0.9200 |
| 17:41862907:C:CC | donor_gain | 0.9200 |
| 17:41864838:TCCAG:T | donor_gain | 0.9200 |
| 17:41864839:CCAGC:C | donor_gain | 0.9200 |
AlphaMissense
4654 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41853946:A:G | W641R | 1.000 |
| 17:41853946:A:T | W641R | 1.000 |
| 17:41854023:C:T | G615E | 1.000 |
| 17:41854491:C:T | G459E | 1.000 |
| 17:41854570:A:G | W433R | 1.000 |
| 17:41854570:A:T | W433R | 1.000 |
| 17:41854629:C:T | G413E | 1.000 |
| 17:41854706:C:A | W387C | 1.000 |
| 17:41854706:C:G | W387C | 1.000 |
| 17:41854708:A:G | W387R | 1.000 |
| 17:41854708:A:T | W387R | 1.000 |
| 17:41854729:A:C | Y380D | 1.000 |
| 17:41854773:C:T | G365E | 1.000 |
| 17:41855050:A:G | W273R | 1.000 |
| 17:41855050:A:T | W273R | 1.000 |
| 17:41855233:C:G | A212P | 1.000 |
| 17:41855280:A:G | L196P | 1.000 |
| 17:41855291:A:C | C192W | 1.000 |
| 17:41855292:C:T | C192Y | 1.000 |
| 17:41864833:C:G | A180P | 1.000 |
| 17:41864841:A:G | L177P | 1.000 |
| 17:41864880:C:A | G164V | 1.000 |
| 17:41864881:C:A | G164W | 1.000 |
| 17:41865006:A:G | F122S | 1.000 |
| 17:41865087:T:A | D95V | 1.000 |
| 17:41865108:C:G | R88P | 1.000 |
| 17:41853900:G:T | A656D | 0.999 |
| 17:41853916:G:T | R651S | 0.999 |
| 17:41853944:C:A | W641C | 0.999 |
| 17:41853944:C:G | W641C | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000043828 (17:41864776 T>C), RS1000049906 (17:41861591 C>G), RS1000142918 (17:41861373 C>T), RS1000251684 (17:41854632 G>A), RS1000512178 (17:41866479 A>G), RS1002161785 (17:41850060 C>A), RS1002190295 (17:41856734 T>A), RS1002384469 (17:41863300 C>A,T), RS1002764446 (17:41851928 A>T), RS1002948506 (17:41859429 G>A), RS1003146124 (17:41858110 G>A), RS1003468047 (17:41866435 G>A), RS1003850633 (17:41857424 T>G), RS1003962952 (17:41864194 C>A,G), RS1005040020 (17:41849975 T>C)
Disease associations
OMIM: gene MIM:619078 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002386_187 | High light scatter reticulocyte percentage of red cells | 9.000000e-35 |
| GCST90002387_30 | Immature fraction of reticulocytes | 6.000000e-41 |
| GCST90002405_328 | Reticulocyte count | 7.000000e-25 |
| GCST90002406_461 | Reticulocyte fraction of red cells | 2.000000e-22 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6196121 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression | 2 |
| Estradiol | increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| testosterone undecanoate | increases expression | 1 |
| methylparaben | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| ferrous chloride | increases expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Plant Oils | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vanadates | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Palmitic Acid | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL6094267 | Binding | Binding affinity to KLHL11 (unknown origin) at 10 uM by thermal shift assay | Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.